Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis research hub

Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis

This study is testing a new medicine, Tarperprumig, for adults with a condition called ANCA-associated vasculitis. It aims to see how safe the medicine is and if it helps treat the condition, compared to a dummy medicine, to find better ways to manage this illness.